← Evidence map

ReviewOncogene2015

Posttranslational modifications of RUNX1 as potential anticancer targets.

S Goyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25263451